OrbitalRx, Inc.

CIK 1740062 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OrbitalRx, Inc..

Recent SEC filings

FiledFormAccession number
Oct 20, 2025D0001740062-25-000003
Mar 5, 2025D0001740062-25-000001
Oct 9, 2024D0001740062-24-000004
Aug 9, 2024D0001740062-24-000003
Mar 2, 2020D/A0001740062-20-000002
Feb 28, 2020D0001740062-20-000001
Aug 29, 2019D/A0001740062-19-000002
Feb 4, 2019D/A0001740062-19-000001
Oct 5, 2018D0001740062-18-000003
May 10, 2018D0001740062-18-000001